# OnCo record cb-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cb-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cb-101" ;
  schema:name "CB-101"@en ;
  schema:description "CB-101 is a three-armed antibody from XTOP Biotherapeutics that steers T cells to tumour cells carrying both ROR1 and EpCAM, in laboratory development for colon, pancreatic and lung cancers."@en ;
  schema:url <https://onco.cc/drugs/cb-101/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.xtopbiotherapeutics.com/pipeline/pipeline>, <https://reporter.nih.gov/project-details/11407471> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Trispecific antibody (T-cell engager)" ;
  onco:technologies <https://onco.cc/technologies/trispecific-antibodies/> ;
  onco:targets <https://onco.cc/targets/ror1/>, <https://onco.cc/targets/epcam/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/xtop-biotherapeutics/> .
